Medical Services International Marketing Program Shows Results
30 March 2007 - 3:49AM
PR Newswire (US)
EDMONTON, Alberta, March 29 /PRNewswire-FirstCall/ -- Medical
Services International Inc (OTC:MSITF) is pleased to announce that
its marketing program for the VScan rapid test kits is showing
excellent results. In the last several months the company has
received requests from 37 companies to become distributors of the
VScan products. By fall 2007 the Company expects to sign up a total
of 100 new distributors. This will generate $250,000 US in
distribution fees and a minimum of 500,000 VScan kits orders. The
Company is receiving additional inquiries and requests from
companies and individuals to become distributors each week. To
become a distributor of VScan products, a deposit of $2500 US is
required. Initial orders range from 5000 to 10,000 kits depending
on the location. The interest in being a distributor of the VScan
test kits can be attributed directly to the test results that are
being obtained throughout the world by regulatory agencies. In
addition to kits for the detection of HIV 1&2, the Company is
getting inquiries about the fact that the VScan HIV test kit
detects Subgroup O. This is a new form of HIV that is prevalent in
Africa and is moving to North America. The VScan HIV test kit is
the only rapid test kit available that can test for Subgroup O.
About VScan The VScan rapid test kit is a single use, disposable,
accurate, cost effective, easy to use, test for the screening of
HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever,
West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot
be sold in Canada. Medical Services International Inc trades in the
United States on the NQB Pinksheets under the symbol "MSITF". For
further information, please contact Robert Talbot at (780) 430 6363
or http://www.medicalservicesintl/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc
CONTACT: Robert Talbot of Medical Services International,
+1-780-430-6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright